Research Group
Community Oncology and Prevention Trials
Sponsor
LuZhe Sun
Status
Terminated
NCT ID
NCT02642094
To examine whether rapamycin can reduce malignant markers and aberrant mammary stem/progenitor cells (MaSCs) number in surgical specimens
Intervention
Rapamycin
Condition
Cancer of Breast
Investigators
LuZhe Sun, PhD, Ismail Jatoi, MD